We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+0.75%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.34B
AUM Growth
-$123M
Cap. Flow
-$153M
Cap. Flow %
-11.43%
Top 10 Hldgs %
26.37%
Holding
215
New
22
Increased
46
Reduced
51
Closed
31

Top Buys

Rank Stock Value
1
IMCR icon
Immunocore
IMCR
+$30.1M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$21.3M
3
BWXT icon
BWX Technologies
BWXT
+$17.1M
4
CBAY
Cymabay Therapeutics
CBAY
+$15.2M
5
IMGN
Immunogen Inc
IMGN
+$14M

Top Sells

Rank Stock Value
1
APLS
Apellis Pharmaceuticals
APLS
+$37.8M
2
INSP icon
Inspire Medical Systems
INSP
+$37.4M
3
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$35.7M
4
DICE
DICE Therapeutics, Inc. Common Stock
DICE
+$19.3M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 52.08%
2 Technology 13.86%
3 Industrials 8.87%
4 Energy 5.36%
5 Financials 5.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALNY icon
151
Alnylam Pharmaceuticals
ALNY
$29.3B
– –
-90,351
Closed -$17.2M
APLS
152
DELISTED
Apellis Pharmaceuticals
APLS
– –
-414,419
Closed -$37.8M
CPA icon
153
Copa Holdings
CPA
$5.8B
– –
-37,845
Closed -$4.18M
CROX icon
154
Crocs
CROX
$6.55B
– –
-59,938
Closed -$6.74M
DHI icon
155
D.R. Horton
DHI
$42.3B
– –
-24,554
Closed -$2.99M
DKS icon
156
Dick's Sporting Goods
DKS
$18.7B
– –
-36,387
Closed -$4.81M
ERII icon
157
Energy Recovery
ERII
$443M
– –
-119,062
Closed -$3.33M
FWONK icon
158
Liberty Media Series C
FWONK
$25.8B
– –
-49,189
Closed -$3.58M
GNRC icon
159
Generac Holdings
GNRC
$12.5B
– –
-5,535
Closed -$825K
GTES icon
160
Gates Industrial Corporation Ltd.
GTES
$7.15B
– –
-287,519
Closed -$3.88M
INSP icon
161
Inspire Medical Systems
INSP
$1.74B
– –
-115,187
Closed -$37.4M
KRNT icon
162
Kornit Digital
KRNT
$791M
– –
-76,379
Closed -$2.24M
LVS icon
163
Las Vegas Sands
LVS
$29.6B
– –
-82,212
Closed -$4.77M
CALY
164
Callaway Golf Company
CALY
$3.14B
– –
-360,584
Closed -$7.16M
MTZ icon
165
MasTec
MTZ
$21.9B
– –
-58,385
Closed -$6.89M
POST icon
166
Post Holdings
POST
$3.57B
– –
-3,760
Closed -$326K
SPRY icon
167
ARS Pharmaceuticals
SPRY
$612M
– –
-275,000
Closed -$1.84M
STKL
168
DELISTED
SunOpta
STKL
– –
-275,956
Closed -$1.85M
TEX icon
169
Terex
TEX
$7.74B
– –
-104,238
Closed -$6.24M
TSCO icon
170
Tractor Supply
TSCO
$18B
– –
-8,935
Closed -$395K
TXRH icon
171
Texas Roadhouse
TXRH
$13.7B
– –
-21,214
Closed -$2.38M
ULTA icon
172
Ulta Beauty
ULTA
$24.3B
– –
-797
Closed -$375K
VKTX icon
173
Viking Therapeutics
VKTX
$4B
– –
-68,905
Closed -$1.12M
WCN
174
Waste Connections
WCN
$42B
– –
-14,858
Closed -$2.12M
WING icon
175
Wingstop
WING
$3.18B
– –
-39,649
Closed -$7.94M
4 5 6
7
8

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Nicholas Investment Partners held 215 positions worth $1.34B, down 8.4% from $1.46B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Nicholas Investment Partners withdrew a net $153M in Q3 2023, closing 31 positions and reducing 51 holdings. Its most notable exit was Apellis Pharmaceuticals, an estimated $37.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 54% a quarter earlier, followed by Technology and Industrials.

Against the trend, Nicholas Investment Partners opened a new position in Sarepta Therapeutics worth $22.8M.

  • Nicholas Investment Partners's largest Q3 2023 buy was Sarepta Therapeutics: 188,085 shares worth $22.8M.
  • Nicholas Investment Partners added most to Immunocore in Q3 2023, an estimated $30.1M increase.
  • Nicholas Investment Partners's biggest Q3 2023 reduction was Karuna Therapeutics, Inc. Common Stock, cutting an estimated $12M.
  • Nicholas Investment Partners fully exited Apellis Pharmaceuticals in Q3 2023, selling an estimated $37.8M.
  • Nicholas Investment Partners's ten largest holdings make up 26% of its $1.34B portfolio in Q3 2023.
  • Nicholas Investment Partners opened 22 new positions and closed 31 in Q3 2023.
  • Nicholas Investment Partners's portfolio value fell 8.4% quarter-over-quarter to $1.34B.

Based on Nicholas Investment Partners's 13F filing for Q3 2023, filed 13 Nov 2023.